Stay updated on Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.
Latest updates to the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the intervention details to include a verified status by Arog Pharmaceuticals, Inc. and has revised the version to v2.14.0, while removing the previous type of intervention from v2.13.3.SummaryDifference3%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has added new features for data selection and download options, while several key government health-related URLs have been removed.SummaryDifference14%
- Check61 days agoChange DetectedNew additions include several key health and government websites, such as HHS, NIH, NLM, NCBI, and USA.gov.SummaryDifference0.7%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and enhanced data field selection for studies.SummaryDifference16%
Stay in the know with updates to Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.